134882-Thumbnail Image.png
Description

Difficult to treat cancer patients, specifically those tumors that are metastatic and drug-resistant, prove to have the lowest survival rates when compared to more localized types. The commonplace combination therapies,

Difficult to treat cancer patients, specifically those tumors that are metastatic and drug-resistant, prove to have the lowest survival rates when compared to more localized types. The commonplace combination therapies, surgery, chemotherapy, and radiation, do not usually result in remission and sometimes cannot be done with these specific patients. RNA interference therapeutics, especially those that use short-interfering RNA (siRNA), have given rise to a novel field that employs the mechanisms in the body to silence the gene expression post-transcriptionally.

550.54 KB application/pdf

Download restricted. Please sign in.

Download count: 0

Details

Contributors
Date Created
  • 2016-12
Resource Type
  • Text
  • Machine-readable links